The genetic basis of autosomal dominant familial Mediterranean fever

QJM: An International Journal of Medicine

Volumn 93, Issue 4, 2000, Pages 217-221

  Booth, D R ^a   Gillmore, J D ^a   Lachmann, H J ^a   Booth, S E ^a   Bybee, A ^a   Soyturk M ^b   Akar, S ^b   Pepys, M B ^a   Tunca, M ^b   Hawkins, P N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; MARENOSTRIN; METHIONINE; PROTEIN; PYRIN; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE TRANSMISSION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; NEUTROPHIL; PENETRANCE; PRIORITY JOURNAL;

EID: 0034031649     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/93.4.217     Document Type: Article

References (13)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43:227-53.
2. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17:25-31.
3. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90:797-807.
4. Bernot A, da Silva C, Petit J-L, et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 1998; 7:1317-25.
5. Booth DR, Gillmore JD, Booth SE, Pepys MB, Hawkins PN. Pyrin/marenostrin mutations in familial Mediterranean fever. Q J Med 1998; 91:603-6.
6. Livneh A, Langevitz P, Shinar Y, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Int J Exp Clin Invest 1999; 6:1-6.
7. Samuels J, Aksentijevich I, Torosyan Y, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998; 77:268-97.
8. Aksentijevich I, Torosyan Y, Samuels J, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64:949-62.
9. Cazeneuve C, Sarkisian T, Pêcheux C, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - genetic and therapeutic implications. Am J Hum Genet 1999; 65:88-97.
10. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40:1879-85.
11. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 1231-labeled serum amyloid P component. N Engl J Med 1990; 323:508-13.
12. McDermott MF. Autosomal dominant recurrent fevers. Clinical and genetic aspects. Rev Rheum 1999; 66:484-91.
13. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97:133-44.